NCT07439575 Wound Closure Materials and Techniques in Hip and Knee Arthroplasty
| NCT ID | NCT07439575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bahattin Kemah |
| Condition | Osteoarthritis, Knee |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-11-01 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized clinical study aims to evaluate the effects of different suture materials and wound closure techniques on wound healing, functional outcomes, and postoperative complications in patients undergoing total hip and knee arthroplasty. A total of at least 90 adult patients undergoing primary or aseptic revision lower extremity arthroplasty will be randomized into two groups according to the wound closure material and technique used. All surgeries will be performed by the same surgical team following standardized operative protocols. Primary outcomes include wound-related complications such as prolonged wound drainage, wound dehiscence, surgical site infection, and local inflammatory findings within 90 days postoperatively. Secondary outcomes include operative time, bleeding amount, cosmetic outcomes, and functional scores. The results of this study are expected to help determine the most effective and safe wound closure method in lower extremity arthroplasty.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 30 years * Patients undergoing primary total hip arthroplasty or total knee arthroplasty * Patients undergoing aseptic revision total hip or knee arthroplasty * Surgery performed by the same surgical team * Ability to provide informed consent Exclusion Criteria: * Age \< 30 years * Patients receiving immunosuppressive therapy * Patients with complicated diabetes mellitus * Chronic venous insufficiency * Peripheral arterial disease * Arthroplasty performed due to malignancy * Active or previous surgical site infection
Contact & Investigator
Bahattin Kemah, MD
PRINCIPAL INVESTIGATOR
Umraniye Education and Research Hospital
Frequently Asked Questions
Who can join the NCT07439575 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Osteoarthritis, Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07439575 currently recruiting?
Yes, NCT07439575 is actively recruiting participants. Contact the research team at bahattinkemah.md@gmail.com for enrollment information.
Where is the NCT07439575 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07439575 clinical trial?
NCT07439575 is sponsored by Bahattin Kemah. The principal investigator is Bahattin Kemah, MD at Umraniye Education and Research Hospital. The trial plans to enroll 90 participants.